Suchergebnisse - "Salazar, Ramon"

PubPharm (11)

1

Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets : experience of a comprehensive cancer centre network

enthalten in: Molecular oncology | 2023

von Mulet Margalef, N. | Castillo, C. | Mosteiro, M. | +20

2

Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer : PLATFORM-B Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Vidal, J. | Fernández-Rodríguez, M. | Casadevall, D. | +21

CommentIn: Clin Cancer Res. 2023 Jan 17;29(2):302-304. - PMID 36378102

3

Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

enthalten in: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia | 2021

von Navarro, S. | Cuatrecasas, M. | Hernández-Losa, J. | +9

4

Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status

enthalten in: JAMA oncology | 2018

von Taieb, J. | Kourie, H. | Emile, J. | +18

CommentIn: JAMA Oncol. 2018 Sep 1;4(9):1298. - PMID 30003228

5

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer

enthalten in: Molecular cancer therapeutics | 2017

von Santos, C. | Azuara, D. | Garcia-Carbonero, R. | +19

6

Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies

enthalten in: Molecular cancer therapeutics | 2016

von Azuara, D. | Santos, C. | Lopez-Doriga, A. | +15

7

A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility

enthalten in: Cell | 2016

von Vecchione, L. | Gambino, V. | Raaijmakers, J. | +31

CommentIn: Cell Chem Biol. 2016 May 19;23(5):537-539. - PMID 27203373

8

The consensus molecular subtypes of colorectal cancer

enthalten in: Nature medicine | 2015

von Guinney, J. | Dienstmann, R. | Wang, X. | +37

CommentIn: BMJ. 2015;351:h5433. - PMID 26463584

9

BRAF-induced tumorigenesis is IKKα-dependent but NF-κB-independent

enthalten in: Science signaling | 2015

von Margalef, P. | Colomer, C. | Villanueva, A. | +7

10

A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction

enthalten in: Gut | 2013

von Tian, S. | Simon, I. | Moreno, V. | +7

CommentIn: Gut. 2013 Nov;62(11):1670. - PMID 23532175